SLC29A1 and neoplasm: Considering both outcomes of previous reports on ENT1 expression in PDAC [12,19] and our data (Figure 7D), we hypothesize that length of survival depends on an individual patient’s physiological expression of ENT1 that seems to determine its expression in tumor.